Case Study: Framework and Policy Development

Case Studies
Written By Adam Foster

Project Objective

  • A global pharmaceutical company’s R&D portfolio included several combination products across multiple different disease states

  • The client partnered with Windrose to provide insights on the value of combination products and strategies to maximize their P&MA potential

Windrose Approach

  • We identified and analyzed recent combination therapy analogues to identify key value drivers and trends for market access outcomes

  • To inform decision-making, we developed different combination archetypes based on product indications and approval status

  • We then conducted in-depth interviews with national and regional payers and KOLs to review stakeholder perceptions of the client’s combination therapies and assess potential market access strategies (e.g. managed entry agreements / innovative agreements, payment / financial models, evidence generation)

  • Finally, for each combination archetype, we developed a framework to assess the P&MA opportunity and challenges for future combinations, informed by primary research

Impact

  • Our insights and recommendations helped the client to maximize the value of pipeline combination therapies across key markets

  • The client proceeded with optimized clinical development and commercialization strategies for their combination products portfolio to improve access and price potential

View fullsize

Windrose Consulting Group Analytical Framework
CS6 (2).png
 
Adam Foster
Previous

Windrose Consulting Group acquires Parioforma as part of its global growth strategy to further enhance its capabilities in non-traditional markets.
Next

Case Study: Global Pricing & Market Access Strategy for a Rare Disease Gene Therapy